<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02082717</url>
  </required_header>
  <id_info>
    <org_study_id>IRB # 13-060</org_study_id>
    <nct_id>NCT02082717</nct_id>
  </id_info>
  <brief_title>The Impact of Neut During Potassium Chloride Replacement on Pain and Incidence of Phlebitis</brief_title>
  <acronym>Neut-WKBH</acronym>
  <official_title>The Impact of 4% Sodium Bicarbonate Additive During Potassium Chloride Replacement on Pain and Incidence of Phlebitis for Adult Patients in a Medical Surgical Unit: A Randomized Double Blinded Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baptist Health South Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baptist Health South Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the impact of 4% sodium bicarbonate additive during&#xD;
      peripheral intravenous potassium chloride replacement therapy for adult patients in a&#xD;
      Medical/Surgical unit. Using a randomized controlled double blinded experimental study&#xD;
      design, patients who are 21 years or older are alert, awake, and oriented at the time of&#xD;
      enrollment and have been ordered peripheral intravenous potassium chloride replacement will&#xD;
      be recruited from one Medical/Surgical during the first 24-48 hours of their admission.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The specific aim of the study is:&#xD;
&#xD;
      Aim 1: To compare patient outcomes (phlebitis, pain at peripheral IV insertion site,&#xD;
      frequency of changing IV access, and time for administration) between the experimental (4%&#xD;
      sodium bicarbonate additive during peripheral intravenous potassium chloride replacement&#xD;
      therapy) and control (standard of practice of no 4% sodium bicarbonate additive during&#xD;
      peripheral intravenous potassium chloride replacement therapy) groups.&#xD;
&#xD;
      Aim 2: To compare number and type of nursing interventions done during peripheral intravenous&#xD;
      potassium chloride replacement therapy between the experimental (4% sodium bicarbonate&#xD;
      additive during peripheral intravenous potassium chloride replacement therapy) and control&#xD;
      (standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous&#xD;
      potassium chloride replacement therapy) groups.&#xD;
&#xD;
      Aim 3: To compare attrition rates and reasons between the experimental (4% sodium bicarbonate&#xD;
      additive during peripheral intravenous potassium chloride replacement therapy) and control&#xD;
      (standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous&#xD;
      potassium chloride replacement therapy) groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Terminated due to medical supplies shortages due to the 2017 hurricane season.&#xD;
  </why_stopped>
  <start_date type="Actual">February 25, 2014</start_date>
  <completion_date type="Actual">August 3, 2018</completion_date>
  <primary_completion_date type="Actual">August 3, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Indicated Findings</measure>
    <time_frame>Up to 4 hours</time_frame>
    <description>outcomes - phlebitis, pain at peripheral intravenous insertion site, frequency of changing IV access, and time for administration.&#xD;
experimental - 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy.&#xD;
control - standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Nursing Interventions</measure>
    <time_frame>Up to 4 hours</time_frame>
    <description>experimental - 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy&#xD;
control - standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Attrition Rates</measure>
    <time_frame>Up to 4 hours</time_frame>
    <description>experimental - 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy.&#xD;
control - standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Hypokalemia</condition>
  <arm_group>
    <arm_group_label>Neut (4%sodium bicarbonate additive)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4% sodium bicarbonate additive during intravenous potassium chloride replacement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard of practice potassium chloride replacement (with no additive)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>potassium chloride replacement</intervention_name>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Neut (4%sodium bicarbonate additive)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Experimental - 4% Sodium Bicarbonate</intervention_name>
    <arm_group_label>Neut (4%sodium bicarbonate additive)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  admitted to the medical/surgical unit within the last 24 to 48 hours&#xD;
&#xD;
          -  awake, alert, and oriented times three&#xD;
&#xD;
          -  21 years old and greater&#xD;
&#xD;
          -  receiving first peripheral intravenous potassium chloride replacement therapy as&#xD;
             ordered by physician or ARNP as part of care and regardless of research&#xD;
&#xD;
          -  potassium level of 3.5 mmol/L or less.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients who have been in the medical/surgical unit more than 48 hours.&#xD;
&#xD;
          -  altered mental status defined as not being awake, alert, and oriented times three&#xD;
&#xD;
          -  patients who already received intravenous potassium chloride replacement during the&#xD;
             current admission and with the current IV access&#xD;
&#xD;
          -  patients receiving intravenous potassium replacement therapy through a central line&#xD;
&#xD;
          -  patients that are not ordered potassium replacement by physician or ARNP as part of&#xD;
             their care while hospitalized.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mavel Arinal, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>BHSF</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>West Kendall Baptist Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33196</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 24, 2014</study_first_submitted>
  <study_first_submitted_qc>March 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2014</study_first_posted>
  <results_first_submitted>September 18, 2020</results_first_submitted>
  <results_first_submitted_qc>March 5, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 1, 2021</results_first_posted>
  <last_update_submitted>March 5, 2021</last_update_submitted>
  <last_update_submitted_qc>March 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phlebitis</mesh_term>
    <mesh_term>Hypokalemia</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 4, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/17/NCT02082717/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Neut (4%Sodium Bicarbonate Additive)</title>
          <description>4% sodium bicarbonate additive during intravenous potassium chloride replacement.&#xD;
potassium chloride replacement&#xD;
Experimental - 4% Sodium Bicarbonate</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>standard of practice potassium chloride replacement (with no additive)&#xD;
potassium chloride replacement</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Neut (4%Sodium Bicarbonate Additive)</title>
          <description>4% sodium bicarbonate additive during intravenous potassium chloride replacement.&#xD;
potassium chloride replacement&#xD;
Experimental - 4% Sodium Bicarbonate</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>standard of practice potassium chloride replacement (with no additive)&#xD;
potassium chloride replacement</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="17"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Indicated Findings</title>
        <description>outcomes - phlebitis, pain at peripheral intravenous insertion site, frequency of changing IV access, and time for administration.&#xD;
experimental - 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy.&#xD;
control - standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy.</description>
        <time_frame>Up to 4 hours</time_frame>
        <population>Due to the small number of participants enrolled, the statistical power would be too low for any significant findings.</population>
        <group_list>
          <group group_id="O1">
            <title>Neut (4%Sodium Bicarbonate Additive)</title>
            <description>4% sodium bicarbonate additive during intravenous potassium chloride replacement.&#xD;
potassium chloride replacement&#xD;
Experimental - 4% Sodium Bicarbonate</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>standard of practice potassium chloride replacement (with no additive)&#xD;
potassium chloride replacement</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Indicated Findings</title>
          <description>outcomes - phlebitis, pain at peripheral intravenous insertion site, frequency of changing IV access, and time for administration.&#xD;
experimental - 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy.&#xD;
control - standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy.</description>
          <population>Due to the small number of participants enrolled, the statistical power would be too low for any significant findings.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain at 15 min. at IV site</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at 1 hour at IV site</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                    <count group_id="O2" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at 2 hours at IV site</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="5"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at 3 hours at IV site</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at 4 hours at IV site</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at completion</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phlebitis (Erythema and Swelling at IV site) at 15 mins.</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phlebitis (Erythema and Swelling at IV site) at 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                    <count group_id="O2" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phlebitis (Erythema and Swelling at IV site) at 2 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="5"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phlebitis (Erythema and Swelling at IV site) at 3 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phlebitis (Erythema and Swelling at IV site) at 4 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slight pain and redness at IV site at 15 min</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slight pain and redness at IV site at 1 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                    <count group_id="O2" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slight pain and redness at IV site at 2 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="5"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slight pain and redness at IV site at 3 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slight pain and redness at IV site at 4 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slight pain and redness at IV site at completion</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Nursing Interventions</title>
        <description>experimental - 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy&#xD;
control - standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy</description>
        <time_frame>Up to 4 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neut (4%Sodium Bicarbonate Additive)</title>
            <description>4% sodium bicarbonate additive during intravenous potassium chloride replacement.&#xD;
potassium chloride replacement&#xD;
Experimental - 4% Sodium Bicarbonate&#xD;
3 participants out of 8 analyzed had pain medication during randomization.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>standard of practice potassium chloride replacement (with no additive)&#xD;
potassium chloride replacement&#xD;
O participants out of 9 had no interventions</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Nursing Interventions</title>
          <description>experimental - 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy&#xD;
control - standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Nursing Intervention - Pain medication</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No nursing intervention</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Attrition Rates</title>
        <description>experimental - 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy.&#xD;
control - standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy</description>
        <time_frame>Up to 4 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neut (4%Sodium Bicarbonate Additive)</title>
            <description>4% sodium bicarbonate additive during intravenous potassium chloride replacement.&#xD;
potassium chloride replacement&#xD;
Experimental - 4% Sodium Bicarbonate&#xD;
Zero attrition rate</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>standard of practice potassium chloride replacement (with no additive)&#xD;
potassium chloride replacement&#xD;
Zero attrition rate</description>
          </group>
        </group_list>
        <measure>
          <title>Attrition Rates</title>
          <description>experimental - 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy.&#xD;
control - standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 4 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Neut (4%Sodium Bicarbonate Additive)</title>
          <description>4% sodium bicarbonate additive during intravenous potassium chloride replacement.&#xD;
potassium chloride replacement&#xD;
Experimental - 4% Sodium Bicarbonate</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>standard of practice potassium chloride replacement (with no additive)&#xD;
potassium chloride replacement</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Diana D'Orazio-Garcia</name_or_title>
      <organization>Baptist Health South Florida</organization>
      <phone>786-594-9737</phone>
      <email>DianaDO@baptisthealth.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

